FDA approves new heart failure combination therapy The US Food and Drug Administration has approved a new drug for heart failure that has “overwhelming benefit” for patients, according to the researchers who trialled the medicine.…
Cystic fibrosis therapy approved by US Food and Drug Administration A combination therapy of two drugs that target the most common genetic mutation responsible for cystic fibrosis has been given a licence in the United States.…
Nivolumab granted positive scientific opinion under UK early access scheme Nivolumab, a new lung cancer drug, has been granted a positive scientific opinion by the UK medicines safety regulator under the Early Access to Medicines Scheme (EAMS).…
Public needs to understand the risks of purchasing medicines online A new EU system enables the public to verify websites that sell medicines, but it will only work if people know about it and want to use a legal site.…
Panobinostat set for approval in Europe as multiple myeloma treatment The multiple myeloma drug panobinostat has received a positive opinion from the European Medicines Agency for the treatment of relapsed or refractory disease.…
Asfotase alfa gets EU greenlight for rare bone condition The first treatment in Europe available for patients with the rare bone disease hypophosphatasia is a step closer following a recommendation from the medicines safety watchdog.…
Australia moves to allow biosimilar substitution The independent body that advises the Australian government about which drugs it should subsidise has taken steps towards allowing pharmacists and clinicians to substitute a biosimilar product for a biologic therapy.…
Free trade agreements play a dangerous game with public health Public health could be sacrificed in large trade pacts that are discussed in secrecy.…
Cangrelor approved for use in the United StatesCangrelor has been approved for use in adult patients undergoing percutaneous coronary intervention in the United States, following a decision by the US Food and Drug Administration.…
Global crackdown on illegal internet trade yields £51.6m worth of medicines and devices An international crackdown on the illegal internet trade in medicines has yielded £51.6m worth of items from 115 different countries.…